In-Ho Kim

机构：Inje University Haeundae Paik Hospital, The Catholic University of Korea Seoul St. Mary's Hospital, Sungkyunkwan University, Catholic University of Korea · ORCID：0000-0003-1339-3459

发表论文 73 篇 · 总被引 901 次 · h-index 14

代表论文

• Development and validation of a prognostic and predictive 32-gene signature for gastric cancer (2022 · Nature Communications · 被引 117)
• Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression (2023 · Journal of Clinical Medicine · 被引 26)
• The Frontline Immunotherapy-Based Treatment of Advanced Clear Cell Renal Cell Carcinoma: Current Evidence and Clinical Perspective (2022 · Biomedicines · 被引 21)
• Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis (2024 · Gastric Cancer · 被引 14)
• Neoadjuvant docetaxel, oxaliplatin, and s-1 plus surgery and adjuvant s-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial. (2023 · Journal of Clinical Oncology · 被引 14)
• Prognostic model in patients with metastatic urothelial carcinoma receiving immune checkpoint inhibitors after platinum failure (2022 · Current Problems in Cancer · 被引 10)